Valeant Still Holding Off On DTC Ads For Controversial Female Sex Pill
This article was originally published in The Pink Sheet Daily
Executive Summary
The female libido enhancing drug Addyi (flibanserin) has drawn a lot of attention, but the sponsor is making less of a splash with the launch.
You may also be interested in...
Female Libido Booster Found In Supplements: Health And Wellness Industry News
Addyi ingredient found in Organic Herbal Supply products; FDA, Australia recognize food safety systems as comparable; and researchers show B vitamins could have a role in reducing the impact of air pollution on the epigenome.
In Recommending Flibanserin Approval, FDA Panelists Urge Alcohol Contraindication
Panel’s vote to approve Sprout’s female sexual dysfunction drug is conditioned on a REMS and possible contraindication with alcohol use; questions about drug’s date rape potential, breast cancer finding in mice addressed.
Moderna's Valera Takes mRNA Approach To Combat Zika
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.